SCHEMBL4422900

SCHEMBL4422900

C=C(C)C(=O)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
THRB P10828 1/20 0.35
TSHR P16473 3/20 0.33
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3295003 1.00 ALDH1A1 (0.41) ALDH1A1THRBTSHRHSD17B10TDP1
SCHEMBL3297294 1.00 ALDH1A1 (0.41) ALDH1A1THRBTSHRHSD17B10TDP1
SCHEMBL5711152 1.00 ALDH1A1 (0.41) ALDH1A1THRBTSHRHSD17B10TDP1
SCHEMBL2407879 0.96 ALDH1A1 (0.44) ALDH1A1THRBTSHRHSD17B10TDP1
SCHEMBL17589284 0.93 ALDH1A1 (0.46) ALDH1A1THRBTSHRHSD17B10TDP1
SCHEMBL3400820 0.91 ALDH1A1 (0.48) ALDH1A1THRBTSHRHSD17B10TDP1
SCHEMBL3446620 0.86 ALDH1A1 (0.52) ALDH1A1THRBTSHRHSD17B10TDP1
SCHEMBL8352527 0.82 ALDH1A1 (0.41) ALDH1A1THRBTSHR
SCHEMBL5559882 0.79 HSD17B10 (0.31) ALDH1A1TSHRHSD17B10TDP1
SCHEMBL1087490 0.79 HSD17B10 (0.31) ALDH1A1TSHRHSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070196326-A1 Process for the preparation of polyorganosilylated carboxylate monomers or polymers thereof SIGMA COATINGS B.V. (NL) 2007-08-23 US claimed
US-20060252953-A1 Process for the production of silyl carboxylate monomers SIGMA COATINGS B.V. (NL) 2006-11-09 US claimed
EP-1795551-B1 Polyorganosilylated carboxylate monomers and polymers and process for the preparation thereof SIGMAKALON SERVICES B V (NL) 2009-12-30 EP disclosed
EP-1795551-A1 Polyorganosilylated carboxylate monomers and polymers and process for the preparation thereof Sigmakalon Services B.V. (NL) 2007-06-13 EP disclosed
EP-1427736-B1 PROCESS FOR THE PREPARATION OF ORGANOSILYLATED CARBOXYLATE MONOMERS, AND THEIR USE IN ANTIFOULING COATINGS SIGMA COATINGS BV (NL) 2006-11-15 EP disclosed
US-7122692-B2 Process for the preparation of organosilylated carboxylate monomers, and their use in antifouling coatings SIGMA COATINGS B.V. (NL) 2006-10-17 US disclosed
US-20050014963-A1 Process for the preparation of organosilylated carboxylate monomers, and their use in antifouling coatings SIGMA COATINGS B.V. (NL) 2005-01-20 US disclosed
EP-1427736-A1 PROCESS FOR THE PREPARATION OF ORGANOSILYLATED CARBOXYLATE MONOMERS, AND THEIR USE IN ANTIFOULING COATINGS SIGMA COATINGS B.V. (NL) 2004-06-16 EP disclosed
WO-2003027124-A1 PROCESS FOR THE PREPARATION OF ORGANOSILYLATED CARBOXYLATE MONOMERS, AND THEIR USE IN ANTIFOULING COATINGS SIGMA COATINGS B.V. (NL) 2003-04-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252953-A1 Process for the production of silyl carboxylate monomers ACSL1, SUCLA2, MSMO1 ALDH1A1 47/4885THRB 4691/4885TSHR 4873/4885
US-20050014963-A1 Process for the preparation of organosilylated carboxylate monomers, and their use in antifouling coatings ACMSD, MMAB, GFER ALDH1A1 367/4885THRB 3294/4885TSHR 4195/4885
US-20070196326-A1 Process for the preparation of polyorganosilylated carboxylate monomers or polymers thereof PRMT9, MRPL9, CD59 ALDH1A1 1429/4885THRB 2956/4885TSHR 1481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.